Physician profile
Michael A Valente
NPI 1578756078
$4,634.36
in general payments reported to CMS, 2019-2025
14 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $117 · 2021: $328 · 2022: $332 · 2023: $373 · 2024: $1,279 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,976.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $863.82 | 2019-2025 | Echelon Flex, Echelon Circular, Enseal |
| Mimedx Group, INC. | $821.75 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $718.54 | 2022-2025 | |
| Medtronic, INC. | $614.29 | 2021-2025 | Ligasure, Eea, Interstim |
| Conmed Corporation | $329.18 | 2019-2021 | |
| Prescient Surgical | $281.77 | 2019 | |
| Dilon Technologies, INC. | $254.28 | 2025 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $233.66 | 2023-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $150.99 | 2021-2022 | |
| Applied Medical Resources Corporation | $114.93 | 2024-2025 | Gelport Laparoscopic System |
| Covidien LP | $104.54 | 2019 | |
| Integra Lifesciences Corporation | $87.44 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $47.62 | 2023 | Hillrom - Fcs 700 Boom |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Valente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.